AASANDHA SCHEME
Master Medicine and Consumable list as at 14th May 2026
test
| Code | mfda_code | Generic | Product name | Strength | Volume | Preparation | Master Price (MVR) |
|---|---|---|---|---|---|---|---|
| TM0621 | P3924 | Lactulose | Lactulose | 80 g | Oral Solution (Powder) | 66.3 | |
| M1488 | P0669 | Lamotrigine | Lamictal | 25 mg | Tablet | 4.08 | |
| M1489 | P0670 | Lamotrigine | Lamictal | 50 mg | Tablet | 5.1 | |
| M1490 | P1619 | Lamotrigine | Lamotrigine | 25 mg | Tablet | 3.67 | |
| M1491 | P1620 | Lamotrigine | Lamotrigine | 50 mg | Tablet | 5.1 | |
| M1492 | P1621 | Lamotrigine | Lamitor | 100 mg | Tablet | 8.67 | |
| TM0173 | P2546 | Lamotrigine | Lamotrigine | 150 mg | Tablet | 10.2 | |
| M1494 | P0274 | Lansoprazole | Lanzol | 15 mg | Capsule | 3.06 | |
| M1495 | P1892 | Lansoprazole | Lanso | 30 mg | Tablet | 2.65 | |
| M1496 | P1907 | Lansoprazole | Lansol | 30 mg | Capsule | 3.06 | |
| M1497 | P2266 | Lansoprazole | Chexid | 30 mg | Capsule | 3.06 | |
| M1498 | P2521 | Lansoprazole | Selanz Sr | 30 mg | Capsule (SR) | 4.08 | |
| M3161 | P2227 | Lansoprazole | Milan | 30 mg | Capsule | 5.1 | |
| TM0430 | P3394 | Lansoprazole + Clindamycin + Tinidazole | Lansoprazole+ Clindamycin+Tinidazole | 300 mg + 300 mg + 500 mg | Tablet | 102 | |
| TM0431 | P3395 | Lansoprazole + Clindamycin + Tinidazole | Lansoprazole+ Clindamycin+Tinidazole | 300 mg + 300 mg + 500 mg | Capsule | 102 | |
| TM0358 | P3292 | Lanthanum Carbonate | Lanthanum Carbonate | 1000 mg | Tablet | 5.1 | |
| TM0522 | P3191 | Lanthanum Carbonate | Lanthanium Carbonate | 500 mg | Tablet (Chewable) | 5.1 | |
| TM0523 | P3192 | Lanthanum Carbonate | Lanthanium Carbonate | 750 mg | Tablet (Chewable) | 9.18 | |
| TM0622 | P3897 | Lanthanum Carbonate | Lanthanum Carbonate | 250 mg | Tablet | 12.24 | |
| TM0524 | P1444 | Lecithin | Lecithin (Essential L) | 250 mg | Capsule | 3.06 |